In HCC models, KSR2 knockdown suppresses proliferation and migration, whereas KSR2 overexpression enhances malignant phenotypes, increases MEK and ERK phosphorylation, and attenuates the growth-inhibitory effects of sorafenib [153]. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.